Related Experiment Video
Updated: May 29, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance
Hongfei Jiang1, Hang Hu, Xiaomei Tong
1Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, #3 East Qing Chun Road, Hangzhou, 310016, Zhejiang, China.
Abstract:
S100P is a 95-amino-acid protein and a member of the S100 family. It was first purified from placenta. The promoter area of S100P has binding sites for SMAD, STAT/CREB and SP/KLF, key regulatory elements participating in transcriptional activation of the S100P gene. Increased levels of S100P have been observed in multiple tumor cell lines and breast, pancreas, lung and ovary carcinomas. S100P has been shown to mediate tumor growth, metastasis and invasion through the binding of Ca(2+) ions, receptor for advanced glycation end products, cytoskeletal protein ezrin, calcyclin-binding protein/Siah-1-interacting protein and cathepsin D. S100P could potentially serve as diagnostic marker, prognostic/predictive indicator and therapy target for different carcinomas.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Survival Analysis
The Tumor Microenvironment
Selectins

